HEATHER DEMORY: Open Payments
NPI 1508911850 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,709 in 132 payments from 19 companies in 2025. Trend: 2023 $2,746 · 2024 $2,622 · 2025 $2,709
Food & beverage: $2,520Education: $189
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $517 |
| ABBVIE INC. | 24 | $413 |
| Lilly USA, LLC | 8 | $251 |
| Regeneron Healthcare Solutions, Inc. | 5 | $211 |
| UCB, Inc. | 7 | $173 |
| PFIZER INC. | 9 | $172 |
| Incyte Corporation | 12 | $144 |
| GENZYME CORPORATION | 4 | $143 |
| Novartis Pharmaceuticals Corporation | 4 | $109 |
| Organon LLC | 6 | $107 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, Bimzelx, CIBINQO, OPZELURA, TALTZ.
Industry payments across MD — which companies pay providers there.
